Differential activation of T cells by natural antigen peptide analogues: Influence on autoimmune and alloimmune in vivo T cell responses

Journal of Immunology

Volumn 160, Issue 10, 1998, Pages 4768-4775

  Soares, Luis R B ^a   Orr, Patricia L ^a   Garovoy, Marvin R ^a   Benichou, Gilles ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNITY; CROSS REACTION; GRAFT REJECTION; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; AUTOIMMUNITY; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNIZATION; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; LYMPHOKINES; MICE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032524938     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Babbitt, B. P., P. M. Allen, G. Matsueda, E. Haber, and E. R. Unanue. 1985. Binding of immunogenic peptides to Ia histocompatibility molecules. Nature 317:359.
2. Townsend, A. R., J. Rothbard, F. M. Gotch, G. Bahadur, D. Wraith, and A. J. McMichael. 1986. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44:959.
3. Lorenz, R., and P. M. Allen. 1988. Processing and presentation of self proteins. Immunol. Rev. 106:115.
4. de Koster, H. S., D. C. Anderson, and A. Termijtelen. 1989. T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP. J. Exp. Med. 169:1191.
5. Chicz, R. M., R. G. Urban, J. C. Gorga, D. A. Vignali, W. S. Lane, and J. L. Strominger. 1993. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178:27.
6. Rudensky, A., P. Preston-Hurlburt, S. C. Hong, A. Barlow, and C. A. Janeway, Jr. 1991. Sequence analysis of peptides bound to MHC class II molecules. Nature 353:622.
7. Rotzschke, O., K. Falk, K. Deres, H. Schild, M. Norda, J. Metzger, G. Jung, and H. G. Rammensee. 1990. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature 348:252.
8. Kappler, J. W., U. Staerz, J. White, and P. C. Marrack. 1988. Self-tolerance eliminates T cells specific for Mis-modified products of the major histocompatibility complex. Nature 332:35.
9. + thymocytes. Nature 333:742.
10. Nikolic-Zugic, J., and M. J. Bevan. 1990. Role of self-peptides in positively selecting the T-cell repertoire. Nature 344:65.
11. Lombardi, G., S. Sidhu, J. R. Batchelor, and R. I. Lechler. 1989. Allorecognition of DR1 by T cells from a DR4/DRw13 responder mimics self-restricted recognition of endogenous peptides. Proc. Natl. Acad. Sci. USA 86:4190.
12. Benichou, G., P. A. Takizawa, C. A. Olson, M. McMillan, and E. E. Sercarz. 1992. Donor major hislocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J. Exp. Med. 175:305.
13. Sette, A., J. Alexander, J. Ruppert, K. Snoke, A. Franco, G. Ishioka, and H. M. Grey. 1994. Antigen analogs/MHC complexes as specific T cell receptor antagonists. Annu. Rev. Immunol. 12:413.
14. Sloan-Lancaster, J., and P. M. Allen. 1995. Significance of T-cell stimulation by altered peptide ligands in T cell biology. Curr. Opin. Immunol. 7:103.
15. Sloan-Lancaster, J., and P. M. Allen. 1996. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 14:1.
16. Racioppi, L., F. Ronchese, L. A. Matis, and R. N. Germain. 1993. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. J. Exp. Med. 177:1047.
17. Sloan-Lancaster, J., A. S. Shaw, J. B. Rothbard, and P. M. Allen. 1994. Partial T cell signaling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy. Cell 79:913.
18. Ruppert, J., J. Alexander, K. Snoke, M. Coggeshall, E. Herbert, D. McKenzie, H. M. Grey, and A. Sette. 1993. Effect of T-cell receptor antagonism on interaction between T cells and antigen-presenting cells and on T-cell signaling events. Proc. Natl. Acad. Sci. USA 90:2671.
19. Madrenas, J., R. L. Wange, J. L. Wang, N. Isakov, L. E. Samelson, and R. N. Germain. 1995. Zeta phosphorylation without ZAP-10 activation induced by TCR antagonists or partial agonists. Science 267:515.
20. Sloan-Lancaster, J., B. D. Evavold, and P. M. Allen. 1993. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 363:156.
21. Sloan-Lancaster, J., B. D. Evavold, and P. M. Allen. 1994. Th2 cell clonal anergy as a consequence of partial activation. J. Exp. Med. 180:1195.
22. Evavold, B. D., and P. M. Allen. 1991. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 252:1308.
23. Evavold, B. D., J. Sloan-Lancaster, B. L. Hsu, and P. M. Allen. 1993. Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides. J. Immunol. 150:3131.
24. Hollsberg, P., W. E. Weber, F. Dangond, V. Batra, A. Sette, and D. A. Hafler. 1995. Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand. Proc. Natl. Acad. Sci. USA 92:4036.
25. Windhagen, A., C. Scholz, P. Hëollsberg, H. Fukaura, A. Sette, and D. A. Hafler. 1995. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity 2:373.
26. De Magistris, M. T., J. Alexander, M. Coggeshall, A. Altman, F. C. Gaeta, H. M. Grey, and A. Sette. 1992. Antigen analog-major histocompaiibility complexes act as antagonists of the T cell receptor. Cell 68:625.
27. Jameson, S. C., F. R. Carbone, and M. J. Bevan. 1993. Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricied cytotoxic T cells. J. Exp. Med. 177:1541.
28. Jameson, S. C., and M. J. Bevan. 1995. T cell receptor antagonists and partial agonists. Immunity 2:1.
29. Wauben, M. H., C. J. Boog, R. van der Zee, I. Joosten, A. Schlief, and W. van Eden. 1992. Disease inhibition by major histocompatibility complex binding peptide analogues of disease-associated epitopes: more than blocking alone. J. Exp. Med. 176:667.
30. Kuchroo, V. K., J. M. Greer, D. Kaul, G. Ishioka, A. Franco, A. Sette, R. A. Sobel, and M. B. Lees. 1994. A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire. J. Immunol. 153:3326.
31. Franco, A., S. Southwood, T. Arrhenius, V. K. Kuchroo, H. M. Grey, A. Sette, and G. Y. Ishioka. 1994. T cell receptor antagonist peptides are highly effective inhibitors of experimental allergic encephalomyelitis. Eur. J. Immunol. 24:940.
32. Ashton-Rickardt, P. G., A. Bandeira, J. R. Delaney, L. Van Kaer, H. P. Pircher, R. M. Zinkernagel, and S. Tonegawa. 1994. Evidence for a differential avidity model of T cell selection in the thymus. Cell 76:651.
33. Hogquist, K. A., S. C. Jameson, W. R. Heath, J. L. Howard, M. J. Bevan, and F. R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76:17.
34. Hsu, B. L., B. D. Evavold, and P. M. Allen. 1995. Modulation of T cell development by an endogenous altered peptide ligand. J. Exp. Med. 181:805.
35. + thymocytes by T-cell receptor peptide antagonists. Proc. Natl. Acacl. Sci. USA 91:4057.
36. Benichou, G., P. A. Takizawa, P. T. Ho, C. C. Killion, C. A. Olson, M. McMillan, and E. E. Sercarz. 1990. Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides. J. Exp. Med. 172:1341.
37. Gammon, G., E. E. Sercarz, and G. Benichou. 1991. The dominant self and the cryptic self: shaping the autoreactive T-cell repertoire. Immunol. Today 12:193.
38. + T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus, J. Exp. Med. 182:1481.
39. Tam, R. C., E. V. Fedoseyeva, M. Moskalenko, M. R. Garovoy, and G. Benichou. 1996. T cell tolerance is influenced by concomitant T cell recognition of cross-reactive self-peptides. J. Immunol. 156:3765.
40. Maeji, N. J., A. M. Bray, and H. M. Geysen. 1990. Multi-pin peptide synthesis strategy for T cell determinant analysis. J. Immunol. Methods 134:23.
41. Curry, R. C., P. A. Kiener, and G. L. Spitalny. 1987. A sensitive immunochemical assay for biologically active MuIFN-γ J. Immunol. Methods 104:137.
42. + T cell subset expression. Int. Immunol. 6:785.
43. Benichou, G., E. Fedoseyeva, C. A. Olson, H. M. Geysen, M. McMillan, and E. E. Sercarz. 1994. Disruption of the determinant hierarchy on a self-MHC peptide: concomitant tolerance induction to the dominant determinant and priming to the cryptic self-determinant. Int. Immunol. 6:131.
44. Oldstone, M. B. 1987. Molecular mimicry and autoimmune disease. Cell 50:819.
45. Nickerson, C., H. Luthra, and C. David. 1991. Antigenic mimicry and autoimmune diseases. Int. Rev. Immunol. 7:205.
46. Schwartz, R. H., D. L. Mueller, M. K. Jenkins, and H. Quill. 1989. T-cell clonal anergy. Cold Spring Harbor Symp. Quant. Biol. 54:605.
47. Madrenas, J., R. H. Schwartz, and R. N. Germain. 1996. Interleukin 2 production, not the pattern of early T-cell antigen receptor-dependent tyrosine phosphorylation, controls anergy induction by both agonists and partial agonists. Proc. Natl. Acad. Sci. USA 93:9736.
48. Lipham, W. J., T. M. Redmond, H. Takahashi, J. A. Berzofsky, B. Wiggert, G. J. Chader, and I. Gery. 1991. Recognition of peptides that are immunopathogenic but cryptic: mechanisms that allow lymphocytes sensitized against cryptic peptides to initiate pathogenic autoimmune processes. J. Immunol. 146:3757.
49. Lehmann, P. V., T. Forsthuber, A. Miller, and E. E. Sercarz. 1992. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358:155.
50. Mitchison, N. A., and C. O'Malley. 1987. Three-cell-type clusters of T cells with antigen-presenting cells best explain the epitope linkage and noncognate requirements of the in vivo cytolytic response. Eur. J. Immunol. 17:1579.
51. Fedoseyeva, E. V., R. C. Tam, I. A. Popov, P. L. Orr, M. R. Garovoy, and G. Benichou. 1996. Induction of T cell responses to a self-antigen following allotransplaniation. Transplantation 61:679.